Evergen Pushing the Boundaries of Tissue Engineering in Regenerative Medicine

Evergen, formerly known as UF startup RTI Surgical, is advancing innovative medical solutions across the cardiac, sports and orthopedics, plastic and reconstructive surgery, and neuro-spine clinical segments as the only contract development and manufacturing organization (CDMO) in regenerative medicine with a clinically proven, differentiated portfolio of both allograft (human donor) and xenograft (animal source) biomaterials at scale.

“Evergen is a global, world-class regenerative medicine CDMO uniquely positioned as an end-to-end resource—offering medical technology companies and healthcare professionals a comprehensive range of top-quality talent and capabilities, along with an integrated value chain that includes design, research and development, regulatory support, verification and validation, manufacturing, and supply chain management solutions,” Olivier Visa, Pharm.D., president and CEO of Evergen, says in an interview.

Read more about Evergen Pushing the Boundaries of Tissue Engineering in Regenerative Medicine.